bHLH Transcription factors inhibitors for cancer therapy: general features for in silico drug design

ResourcesPatient ResourcesTestimonialsbHLH Transcription factors inhibitors for cancer therapy: general features for in silico drug design

bHLH Transcription factors inhibitors for cancer therapy: general features for in silico drug design

  • Date: December 30, 2014
  • Type:
  • Size:

Download